Shell Asset Management CO Arcturus Therapeutics Holdings Inc. Transaction History
Shell Asset Management CO
- $2.27 Billion
- Q3 2024
A detailed history of Shell Asset Management CO transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 12,554 shares of ARCT stock, worth $213,041. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,554
Previous 12,869
2.45%
Holding current value
$213,041
Previous $313,000
7.03%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding ARCT
# of Institutions
174Shares Held
25.5MCall Options Held
195KPut Options Held
133K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$79.7 Million0.25% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$45 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.32MShares$39.3 Million0.62% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.1MShares$35.7 Million0.46% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.07MShares$35 Million0.02% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $451M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...